These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6897751)

  • 1. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
    Randall MJ; Wilding RI
    Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
    Randall MJ; Wilding RI
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of thromboxane synthetase with dazoxiben - basis of its inhibitory effect on platelet adhesion.
    Menys VC; Davies JA
    Thromb Haemost; 1983 Apr; 49(2):96-101. PubMed ID: 6346575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective inhibition of platelet thromboxane synthesis on the platelet-subendothelium interaction.
    De La Cruz JP; Villalobos MA; Escalante R; Guerrero A; Arrebola MM; Sánchez de La Cuesta F
    Br J Pharmacol; 2002 Dec; 137(7):1082-8. PubMed ID: 12429581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J; Defreyn G; Carreras LO; Machin SJ; Van Schaeren J; Verstraete M
    Lancet; 1981 May; 1(8229):1073-5. PubMed ID: 6112447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis.
    Hook BG; Schumacher WA; Lee DL; Jolly SR; Lucchesi BR
    J Cardiovasc Pharmacol; 1985; 7(1):174-81. PubMed ID: 2580139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis.
    Bergqvist D; Björck CG; Dougan P; Esquivel CO; Lannerstad O; Nilsson B; Saldeen P; Saldeen T
    Thromb Res; 1985 Feb; 37(3):435-48. PubMed ID: 3838828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits.
    Hall ER; Chen YC; Ho T; Wu KK
    Thromb Res; 1982 Sep; 27(5):501-11. PubMed ID: 6891109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
    Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
    Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits.
    Mikashima H; Muramoto Y
    Thromb Res; 1990 Feb; 57(4):499-505. PubMed ID: 2326771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
    Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
    Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dazoxiben on platelet-vessel wall interaction.
    Davies JA; Menys VC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):45S-46S. PubMed ID: 6681703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
    Deckmyn H; Van Houtte E; Verstraete M; Vermylen J
    Biochem Pharmacol; 1983 Sep; 32(18):2757-62. PubMed ID: 6578796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.